Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer

BACKGROUND: Bacillus Calmette-Guérin (BCG) unresponsive/relapsing patients with non-muscle invasive bladder cancer (NMIBC) who prefer bladder preservation over radical cystectomy (RC) or those who do not qualify for surgery may be offered intravesical therapies. Gemcitabine (GEM) combined with Docet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bladder Cancer
Hauptverfasser: Milbar, Niv, Kates, Max, Chappidi, Meera R., Pederzoli, Filippo, Yoshida, Takahiro, Sankin, Alexander, Pierorazio, Phillip M., Schoenberg, Mark P., Bivalacqua, Trinity J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: IOS Press 2017
Schlagworte:
Research Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5676758/
https://ncbi.nlm.nih.gov/pubmed/29152553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-170126
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge